Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus pharmacokinetics and donor/recipient genotype study after liver transplantation
ChiCTR-ONC-11001702Phase 4Completed
- Sponsor
- Tianjin First Central Hospital
- Start
- Oct 2009
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in liver transplant, sponsored by Tianjin First Central Hospital. Primary endpoints: C0 and Tacrolimus pharmacokinetics. Started Oct 2009; status: completed.
02
Drugs
tacrolimus
03
Conditions
liver transplant
Beyond the preview
Go deeper on ChiCTR-ONC-11001702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-11001702.